Innovex International, Inc. (INVX)
Innovex International, Inc. (INVX)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents at beginning of period | NaN | NaN | 73,278 | NaN |
| Net income | -16,671 | 13,968 | 39,228 | 30,102 |
| Depreciation and amortization | 16,222 | 15,461 | 15,362 | 29,919 |
| Deferred debt issuance cost amortization | 73 | 73 | 73 | 171 |
| Equity method earnings, net of dividends | NaN | 0 | 0 | 0 |
| Amortization of operating lease rou asset | 3,278 | 3,273 | 3,253 | 5,972 |
| Impairment of long-lived assets | 0 | 0 | 0 | 3,427 |
| Bargain purchase loss (gain) | NaN | 0 | -3,342 | NaN |
| Gain on consolidation of equity method investment | NaN | 0 | NaN | NaN |
| Provision for legal settlement | -48,803 | NaN | NaN | NaN |
| Stock based compensation expense | 2,967 | 5,029 | 3,244 | 5,525 |
| (gain) loss on sale of property, equipment and lease terminations | 2,028 | 40,082 | NaN | NaN |
| Gain on sale of property, equipment and lease terminations | NaN | NaN | 40,850 | 487 |
| Deferred tax, net | 4,361 | 2,974 | 17,424 | 13,893 |
| Trade receivables, net | 10,319 | -13,418 | 3,626 | -7,839 |
| Inventories | 3,057 | -26,162 | -5,999 | -14,464 |
| Prepaid expenses and other current assets | 13,590 | -8,169 | -8,485 | 5,795 |
| Other long-term assets | -636 | 2,101 | 624 | 1,112 |
| Accounts payable | 14,025 | -5,112 | -397 | -7,189 |
| Accrued expenses and other current liabilities | -13,269 | 860 | -7,637 | -12,298 |
| Other operating assets and liabilities, net | 11,591 | 31,191 | -5,098 | -5,869 |
| Net cash provided by operating activities | 19,840 | 52,238 | 48,374 | 90,300 |
| Payments on acquisitions, net of cash acquired | 0 | 2,499 | 500 | 80,669 |
| Capital expenditures | 5,827 | 8,927 | 11,852 | 14,353 |
| Proceeds from sale of property and equipment | 202 | 1,468 | 89,907 | 8,684 |
| Equity method investment | NaN | 0 | NaN | NaN |
| Cash acquired in stock based business combination | NaN | 0 | 0 | NaN |
| Net cash used in investing activities | -5,625 | -9,958 | 77,555 | -86,338 |
| Deferred debt issuance cost | 0 | 0 | 0 | 1,455 |
| Revolving credit facility borrowings | 0 | 0 | 8,000 | 136,200 |
| Revolving credit facility payments | 0 | 0 | 37,000 | 121,200 |
| Term loan payments | 0 | 0 | 0 | 11,429 |
| Subordinated note payments | NaN | 0 | NaN | NaN |
| Payments on finance leases | 2,070 | 2,243 | 1,793 | 3,499 |
| Common stock repurchased and retired | 14,130 | 0 | 0 | 9,280 |
| Dividend payment | NaN | 0 | 0 | NaN |
| Proceeds from exercise of options | NaN | 0 | 0 | NaN |
| Taxes paid related to net share settlement of equity awards | 710 | 542 | 384 | 294 |
| Net cash used in financing activities | -16,910 | -2,785 | -31,177 | -10,957 |
| Effect of exchange rate changes | -5 | 538 | -159 | 2,498 |
| Net change in cash and restricted cash | -2,700 | 40,033 | 94,593 | -4,497 |
| Cash and restricted cash beginning of period | 203,407 | 163,374 | NaN | NaN |
| Cash and cash equivalents at end of period | NaN | NaN | 163,374 | NaN |
| Cash and restricted cash end of period | 200,707 | 203,407 | NaN | NaN |